Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

08-28

Immunogenicity Detection Platform of InnoModels Biotechnology

In the field of biopharmaceuticals, the safety and efficacy of drugs are crucial aspects of the R&D process. Immunogenicity is one of the key indicators for assessing the potential risk of a drug, and the accuracy and reliability of its detection platform directly affects the process and results of new drug development. With its advanced immunogenicity testing platform, InnoModels Biotechnology (Beijing) Co., Ltd. provides strong technical support and guarantee for new drug R&D.

08-27

Introduction to the SCID Mouse NK Efficacy Model of InnoModels Biotechnology

The SCID mouse is a mouse model with an autosomal recessive purist Prkdcscid mutant that causes mice to exhibit severe combined immunodeficiency.SCID mice lack mature T and B lymphocytes but retain some functions of macrophages and NK cells. This model is uniquely advantageous in the efficacy assessment of NK cell-associated drugs because NK cells can function independently in the absence of interference from other immune cells

08-23

Analysis of the technical features of the iHuPBMC-B platform of InnoModels Biotechnology

At the forefront of biomedical research, especially in the fields of tumor immunity, autoimmune diseases, and vaccine development, an efficient and accurate animal model system is crucial for promoting scientific research and technological innovation. With its self-developed iHuPBMC-B platform, InnoModels Biotechnology provides a revolutionary solution for researchers in these fields. This article will introduce the core technical features of iHuPBMC-B platform in detail

08-22

Technical Features of the iHuPBMC-NK Platform from InnoModels Biotechnology

In the field of biomedical research, especially at the forefront of immunotherapy, cancer research and infectious diseases, efficient and precise experimental tools and platforms have become the key to driving scientific progress. With its innovative iHuPBMC-NK platform, InnoModels Biotechnology (Beijing) Co., Ltd. has provided researchers with a revolutionary solution that has greatly facilitated research progress in these fields

< 1...7 8 9...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License